Welt Bio-Molecular Pharmaceutical, LLC

The New York Structural Biology Center is a corporation governed by a Board representing more than 10 institutional members, including the Albert Einstein College of Medicine of Yeshiva University, City University of New York, Memorial Sloan-Kettering Cancer Center and Mount Sinai School of Medicine. It conducts research in the fields of structural genomics and proteomics. The center maintains a more than 22,000-square-foot renovated building that features high-field magnets and a phase II area that accommodates magnets, laboratories, computers, and office and classroom space. The New York Structural Biology Center additionally hosts several seminars and courses related to science and biochemistry. It is located in New York City.

Cresilon, Inc is a Brooklyn-based company specializing in innovative technology solutions for the medical field. Their flagship product, VETIGEL, is a groundbreaking gel that has revolutionized wound care in veterinary medicine. With a team of experienced professionals and a commitment to excellence, Cresilon, Inc is dedicated to improving the lives of animals through cutting-edge advancements in medical technology. Driven by a passion for innovation, Cresilon, Inc has developed a range of products including TRAUMAGEL and Cresilon, which have become trusted trademarks in the industry. With a focus on research and development, the company continues to push the boundaries of medical science, providing effective solutions for wound healing and beyond.Generated from the website

Calder Biosciences, Inc. is a molecular engineering company based in Brooklyn, NY, specializing in the development of innovative vaccines using their proprietary 3D-Vaxlock technology. Their vaccines aim to provide safe, effective, and durable protection against a range of viral infections, including RSV, influenza, and other harmful pathogens. With a focus on global health issues caused by viral infections, Calder Biosciences utilizes state-of-the-art technology and scientific expertise to engineer site-specific, covalent crosslinks in proteins, creating subunit vaccine immunogens that elicit highly protective immune responses. Their commitment to industry leadership, research partnerships, and rigorous safety and efficacy testing positions them as a leading player in the field of vaccine development.Generated from the website